Category News

GE HealthCare has announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, a groundbreaking 3D ultrasound system designed to enhance breast cancer detection in women with dense breast tissue.

GE HealthCare Unveils AI-Powered Invenia ABUS Premium for Early Cancer Detection

GE HealthCare Launches AI-Powered Invenia ABUS Premium for Faster, More Accurate Cancer Detection in Dense Breasts Introduction GE HealthCare has announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, a groundbreaking 3D ultrasound system designed to enhance breast cancer…

Read MoreGE HealthCare Unveils AI-Powered Invenia ABUS Premium for Early Cancer Detection
Precision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B

Precision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B Cure at Global Hepatitis Summit 2025

Precision BioSciences Presents Preclinical Data on PBGENE-HBV at Global Hepatitis Summit 2025 Introduction Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company known for its novel ARCUS® platform, has unveiled promising preclinical data supporting the use of repeat dosing…

Read MorePrecision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B Cure at Global Hepatitis Summit 2025
ICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management

ICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management

ICON Integrates Medidata Clinical Data Studio to Enhance Clinical Trial Efficiency Introduction Medidata, a Dassault Systèmes brand and a global leader in clinical trial solutions, has announced that ICON plc, a leading clinical research organization (CRO), will be integrating the…

Read MoreICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management
Insulet’s RADIANT Trial Shows Glycemic Improvements with Omnipod® 5 After Switching from MDI

Insulet’s RADIANT Trial Shows Glycemic Improvements with Omnipod® 5 After Switching from MDI

Omnipod® 5 RADIANT Trial Shows Significant Glycemic Improvements Following Direct Transition from MDI Insulet Corporation, a leader in tubeless insulin pump technology, has released groundbreaking results from its RADIANT clinical trial, which were presented at the 18th International Conference on…

Read MoreInsulet’s RADIANT Trial Shows Glycemic Improvements with Omnipod® 5 After Switching from MDI
Keysight Launches Solution for Accurate Photonic Circuit Design

Keysight Launches Solution for Accurate Photonic Circuit Design

Keysight Launches Photonic Designer: A Comprehensive Solution for Accurate Photonic Circuit Design Introduction to Photonic Designer Keysight Technologies, Inc. has introduced Photonic Designer, a groundbreaking photonic design automation (PDA) software solution tailored for photonics design engineers. This innovative tool aims…

Read MoreKeysight Launches Solution for Accurate Photonic Circuit Design
AM Batteries and TDK Partner to Advance Energy-Efficient Battery Manufacturing

AM Batteries and TDK Partner to Advance Energy-Efficient Battery Manufacturing

AM Batteries and TDK Collaborate to Advance Energy-Efficient Battery Manufacturing AM Batteries, a leader in dry battery electrode (DBE) technology, has entered into a joint development agreement with TDK Corporation, a global electronics leader. This collaboration aims to advance energy-efficient…

Read MoreAM Batteries and TDK Partner to Advance Energy-Efficient Battery Manufacturing
Precision BioSciences Presents Preclinical Data on PBGENE-DMD for DMD at MDA 2025

Precision BioSciences Presents Preclinical Data on PBGENE-DMD for DMD at MDA 2025

Precision BioSciences Presents Promising Preclinical Data for PBGENE-DMD in Duchenne Muscular Dystrophy at 2025 MDA Conference Introduction to PBGENE-DMD and the DMD Challenge Precision BioSciences, Inc., a clinical-stage gene editing company, has announced the presentation of promising preclinical data for…

Read MorePrecision BioSciences Presents Preclinical Data on PBGENE-DMD for DMD at MDA 2025

Cellares and Cabaletta Bio Complete Rese-cel Manufacturing with Cell Shuttle™ Platform

Cellares and Cabaletta Bio Successfully Complete Technology Adoption Program for Rese-cel Using Cell Shuttle™ Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has successfully concluded the Technology Adoption Program (TAP) for its innovative automated cell therapy manufacturing platform,…

Read MoreCellares and Cabaletta Bio Complete Rese-cel Manufacturing with Cell Shuttle™ Platform